The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.

Wednesday, May 10, 2006
249

Interest in a methamphetamine intervention among men who have sex with men

Timothy William Menza1, Grant Colfax2, Steven Shoptaw3, Mark Fleming4, Robert Guzman2, Jeffrey D. Klausner2, Pamina M. Gorbach5, and Matthew R. Golden6. (1) Department of Epidemiology, Center for AIDS and STD, University of Washington, Harborview Medical Center, 325 Ninth Ave, Box 359931, Seattle, WA, USA, (2) STD Prevention and Control Services, San Francisco Department of Public Health, 1360 Mission St, Suite 401, San Francisco, CA, USA, (3) Friends of Research Institute, Inc, 11075 Santa Monica Blvd. Suite 200, Los Angeles, CA, USA, (4) Public Health, Seattle, WA, USA, (5) Department of Epidemiology and Division of Infectious Disease, UCLA School of Public Health and David Geffen School of Medicine, 10940 Wilshire Blvd, Suite 1220, Los Angeles, CA, USA, (6) Infectious Diseases, Public Health - Seattle & King County, University of Washington, Harborview Medical Center, 325 9th Ave., Box 359777, Seattle, WA, USA


Background:
Few data exist on the acceptability and efficacy of interventions to decrease methamphetamine use among men who have sex with men (MSM) who are not seeking drug treatment and who are at high risk for acquiring or transmitting HIV or other sexually transmitted diseases (STD).

Objective:
To assess the interest of out-of-treatment methamphetamine-using MSM STD clinic patients in an intervention specifically targeting their drug use.

Method:
We surveyed MSM who use methamphetamine seen at two public health STD clinics and evaluated their interest in a hypothetical program designed to help them stop or reduce their MA use.

Result:
A total of 174 MSM completed an anonymous, self-administered questionnaire. Thirty-six percent of respondents reported being considerably or extremely troubled or bothered by their MA use, 45% reported a considerable or extreme desire to reduce or stop their use of methamphetamine, 37% reported considerable or extreme interest in attending a program to stop or decrease methamphetamine use, and 64% reported that they would be considerably or extremely more interested in such a program if a monetary incentive were offered for participation. While 70% of the men surveyed had attempted to stop using methamphetamine, only 12% had ever sought drug treatment.

Conclusion:
In a diverse sample of MSM who use methamphetamine, interest in an intervention to stop or reduce methamphetamine use is high. Interest in such an intervention increased if it was presented as including a monetary incentive. STD clinics can access methamphetamine-using MSM in substantial numbers.

Implications:
Given the large number of high-risk methamphetamine-using MSM seen in STD clinics, the high interest in an intervention with monetary incentive, and the success of voucher-based reinforcement strategies for substance use, contingency management-based programs for methamphetamine-using MSM that are delivered through the public health system merit further investigation.